Albemarle Q2 Sales Jump 31%, Beats Estimates; Slashes Capex Outlook to $500M
ALB sits 80% above its 52-week low of $66.665.
Summary
Albemarle's Q2 net sales rose 31% to $1.74B, beating the $1.62B estimate, with adjusted EPS of $3.75 vs. $3.22 expected. Adjusted EBITDA hit $858M, well above the $779M forecast. The company also cut its full-year capex outlook to about $500M, signaling capital discipline amid rebounding lithium markets. This follows the 8-K and Reuters report yesterday that highlighted net income surging to $480M from $23M a year ago. The capex reduction is a new, material detail that suggests management is prioritizing cash flow and returns over aggressive expansion.
At the time of this announcement, ALB was trading at $120.12 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $14B. The 52-week trading range was $66.67 to $221.00. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Binance News.